DE3069813D1 - Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation - Google Patents

Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation

Info

Publication number
DE3069813D1
DE3069813D1 DE8080200137T DE3069813T DE3069813D1 DE 3069813 D1 DE3069813 D1 DE 3069813D1 DE 8080200137 T DE8080200137 T DE 8080200137T DE 3069813 T DE3069813 T DE 3069813T DE 3069813 D1 DE3069813 D1 DE 3069813D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
diphenylhydantoin
derivative
preparation
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080200137T
Other languages
English (en)
Inventor
Pierre Dumont
Jacques Poupaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
La Region Wallonne
Original Assignee
La Region Wallonne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by La Region Wallonne filed Critical La Region Wallonne
Application granted granted Critical
Publication of DE3069813D1 publication Critical patent/DE3069813D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DE8080200137T 1979-02-20 1980-02-18 Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation Expired DE3069813D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7904209A FR2449448B1 (fr) 1979-02-20 1979-02-20 Composition pharmaceutique comprenant un derive de phenylhydantoine, derives mis en oeuvre et leur preparation

Publications (1)

Publication Number Publication Date
DE3069813D1 true DE3069813D1 (en) 1985-01-31

Family

ID=9222166

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080200137T Expired DE3069813D1 (en) 1979-02-20 1980-02-18 Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation

Country Status (11)

Country Link
US (1) US4304782A (de)
EP (1) EP0015038B1 (de)
JP (1) JPS55133362A (de)
AT (1) ATE10804T1 (de)
CA (1) CA1139672A (de)
DE (1) DE3069813D1 (de)
DK (1) DK71780A (de)
ES (1) ES488788A0 (de)
FI (1) FI71556C (de)
FR (1) FR2449448B1 (de)
NO (1) NO152047C (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106837B2 (ja) * 1989-01-31 1995-11-15 シャープ株式会社 シート状体の循環式供給装置
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
JPH04297461A (ja) * 1991-03-27 1992-10-21 Otsuka Pharmaceut Factory Inc ２−チオヒダントイン誘導体
WO1995026325A2 (en) * 1994-03-25 1995-10-05 Isotechnika Inc. Enhancement of the efficacy of drugs by deuteration
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
AU1917899A (en) * 1998-03-20 1999-10-18 Warner-Lambert Company Crystalline sodium phenytoin monohydrate
EP1066279A4 (de) * 1998-03-25 2004-09-08 Bristol Myers Squibb Co Anorektische imidazolonverbindungen:ii. phenylderivate
DE10214228A1 (de) * 2002-03-22 2003-10-02 Bdd Group Holding Ag Zug Deuterierte substitutierte Indole sowie diese Verbindungen enthaltende Arzneimittel
CA2550447A1 (en) * 2003-12-19 2005-07-07 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies
NZ550102A (en) * 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
PT2656841T (pt) 2006-03-27 2016-09-28 Univ California Modulador do recetor de androgénios para o tratamento de cancro da próstata e doenças associadas ao recetor de androgénios
KR101600230B1 (ko) 2006-03-29 2016-03-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴티오히단토인 화합물
EP2220050A2 (de) 2007-10-26 2010-08-25 The Regents Of The University Of California Diarylhydantoinverbindungen als androgenrezeptormodulatoren
ES2668380T3 (es) 2010-02-16 2018-05-17 Aragon Pharmaceuticals, Inc. Moduladores de receptores de andrógenos y sus usos
SI3305285T1 (sl) 2012-09-26 2021-03-31 Aragon Pharmaceuticals, Inc. Anti-androgeni za zdravljenje proti kastraciji odpornega ne-metastatskega raka
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
JOP20200076A1 (ar) 2017-10-16 2020-04-30 Aragon Pharmaceuticals Inc مضادات أندروجين لعلاج سرطان البروستاتا غير النقيلي المقاوم للاستئصال

Also Published As

Publication number Publication date
EP0015038A1 (de) 1980-09-03
DK71780A (da) 1980-08-21
JPS55133362A (en) 1980-10-17
EP0015038B1 (de) 1984-12-19
US4304782A (en) 1981-12-08
CA1139672A (en) 1983-01-18
ATE10804T1 (de) 1985-01-15
FI71556C (fi) 1987-01-19
FR2449448B1 (fr) 1983-05-27
FI800502A (fi) 1980-08-21
NO800447L (no) 1980-08-21
NO152047C (no) 1985-07-24
FR2449448A1 (fr) 1980-09-19
ES8200011A1 (es) 1981-10-16
NO152047B (no) 1985-04-15
FI71556B (fi) 1986-10-10
ES488788A0 (es) 1981-10-16

Similar Documents

Publication Publication Date Title
DE3069813D1 (en) Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation
IE46158L (en) Propanolamine derivatives
HUP9801356A2 (hu) Triciklusos (2-hidroxi-2-metil-3,3,3-trifluor-propanoil)-amino-benzoxepin-, -benzotiepin-, -benzocikloheptén-, -indén-származékok és az ezeket tartalmazó gyógyszerkészítmények
ATE74352T1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
AU643290B2 (en) Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application
DE3070227D1 (en) Benzothiazole derivatives, pharmaceutical compositions containing them and process for their preparation
NO833528L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutan-derivater
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
SE7403176L (de)
IL59052A0 (en) Hexahydro-1,4-oxazepine derivatives their preparation and pharmaceutical compositions containing them
IL60176A0 (en) Xanthine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
PT90262A (pt) Processo para a preparacao de novos derivados trienicos com estrutura cromenica
ES8201539A1 (es) Procedimiento de preparacion de nuevas ortoarilideneaminofe-netilaminas y de sus sales de adicion con acidos farmacolo- gicamente compatibles
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ES2060095T3 (es) Nuevas imidazobenzodiazepinas y sus sales, procedimiento de preparacion, aplicacion como medicamentos y composiciones que los contienen.
ATE53839T1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Free format text: LEDERER, F., DIPL.-CHEM. DR., PAT.-ANW., 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee